Identification of 4,5-dihydro-4-hydroxygeldanamycins as shunt products of geldanamycin biosynthesis

J Nat Prod. 2012 Aug 24;75(8):1480-4. doi: 10.1021/np3001738. Epub 2012 Jul 31.

Abstract

Two new geldanamycin (GDM) analogues, (4S)-4,5-dihydro-4-hydroxygeldanamycin (1) and (4R)-4,5-dihydro-4-hydroxygeldanamycin (2), were identified from Streptomyces hygroscopicus 17997. Compounds 1 and 2 were not normal intermediates of GDM biosynthesis but shunt products of C-4,5 oxidation catalyzed by GdmP, a cytochrome P450 oxidase acting as a desaturase in GDM biosynthesis. Preliminary assays implied that, compared with GDM, 1 and 2 exhibited decreased cytotoxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzoquinones* / chemistry
  • Benzoquinones* / metabolism
  • Benzoquinones* / pharmacology
  • Lactams, Macrocyclic* / chemistry
  • Lactams, Macrocyclic* / metabolism
  • Lactams, Macrocyclic* / pharmacology
  • Molecular Structure
  • NADPH-Ferrihemoprotein Reductase / metabolism*
  • Nuclear Magnetic Resonance, Biomolecular
  • Oxidation-Reduction
  • Streptomyces / chemistry*
  • Streptomyces / genetics
  • Streptomyces / metabolism

Substances

  • (4S)-4,5-dihydro-4-hydroxygeldanamycin
  • Benzoquinones
  • Lactams, Macrocyclic
  • NADPH-Ferrihemoprotein Reductase
  • geldanamycin